company-logo

Epigral Limited manufactures and sells chlor-alkali and related derivatives in India and internationally. The company offers chlorinated polyvinyl chloride (CPVC) resins, epichlorohydrin, chloromethanes, hydrogen peroxide, caustic soda, chlorine, hydrogen, and caustic potash products. It also trades in agrochemical products. The company serves various sectors, including CPVC pipes and fittings, windmills, construction, paints and coatings, electronics, water treatment, agrochemicals, pharmaceuticals, refineries, soap and detergents, fluoropolymers, paper and pulp, textiles, alumina, polyurethane foam, lithium, and polytetrafluoroethylene (PTFE) pipes. The company was formerly known as Meghmani Finechem Limited and changed its name to Epigral Limited in August 2023. Epigral Limited was incorporated in 2007 and is based in Ahmedabad, India.

Epigral Dividend Announcement

Epigral announced a annually dividend of ₹5.00 per ordinary share which will be made payable on 2024-08-08. Ex dividend date: 2024-07-02
Epigral annual dividend for 2024 was ₹5.00
Epigral annual dividend for 2023 was ₹2.50
Epigral's trailing twelve-month (TTM) dividend yield is 0.25%

Epigral Dividend History

Ex-Div dateDividend amountDividend typePay date
2024-07-02₹5.00annually2024-08-08
2023-06-20₹2.50annually2023-07-27

Epigral Dividend per year

Epigral Dividend Yield

Epigral current trailing twelve-month (TTM) dividend yield is 0.25%. Interested in purchasing Epigral stock? Use our calculator to estimate your expected dividend yield:

Epigral Financial Ratios

P/E ratio33.88
PEG ratio0.89
P/B ratio6.76
ROE42.01%
Payout ratio0.00%
Current ratio0.64
Quick ratio0.31
Cash Ratio0.01

Epigral Dividend FAQ

Does Epigral stock pay dividends?
Epigral does not currently pay dividends to its shareholders.
Has Epigral ever paid a dividend?
No, Epigral has no a history of paying dividends to its shareholders. Epigral is not known for its dividend payments.
Why doesn't Epigral pay dividends?
There are several potential reasons why Epigral would choose not to pay dividends to their shareholders:

1. Growth opportunities: Companies, especially in fast-growing industries like technology, reinvest earnings into expansion, R&D, or acquisitions to fuel future growth and increase company value.

2. Tax implications: Not paying dividends can reduce the tax burden on shareholders, who may prefer to defer taxes until selling shares and realizing capital gains.

3. Investor preferences: Some investors prefer companies to reinvest profits for higher long-term returns, particularly those seeking capital appreciation over income.

4. Capital allocation priorities: Companies may allocate cash to pay down debt, fund share buybacks, or invest in projects with higher returns than dividends.

5. Market expectations: In certain sectors, like technology, reinvesting profits for growth and innovation is often prioritized over distributing dividends to shareholders.
Will Epigral ever pay a dividend?
The decision for a company to pay dividends depends on various factors including its financial performance, growth prospects, capital allocation priorities, and shareholder preferences. While Epigral has not paid dividends historically and has instead focused on reinvesting its earnings for growth, it's ultimately up to the company's management and board of directors to decide whether to initiate a dividend policy in the future.
Is Epigral a dividend aristocrat?
Epigral is not considered a Dividend Aristocrat. The term "Dividend Aristocrat" is typically used to describe a company in the S&P 500 index that has increased its dividend payouts for at least 25 consecutive years.
Is Epigral a dividend king?
Epigral is not classified as a "Dividend King". A Dividend King is a company that has managed to increase its dividend payouts for 50 consecutive years or more, which is an even more selective group than the Dividend Aristocrats.
Is Epigral a dividend stock?
No, Epigral is not considered a dividend stock. A dividend stock is a stock of a company that regularly pays out dividends to its shareholders.
How to buy Epigral stocks?
To buy Epigral you need a brokerage account. Open an account with a reputable brokerage firm that offers access to the stock market. Consider factors such as fees and account minimums.

Place an order: Use the brokerage's trading platform to place an order to buy Epigral stock.

Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.